The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms

ConclusionsCefoperazone-sulbactam at a 1:1 ratio has greater in vitro activity against most multidrug resistant organisms than cefoperazone-sulbactam at a 2:1 ratio. Such combinations were not influenced by the inoculum size of ESBL-producing E. coli and K. pneumoniae and could be a therapeutic option for treating severe infections.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research